Barcellini, Wilma <br/><br/>
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.  [electronic resource] 

 -  Blood  Nov 2014 
 - 2930-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2014-06-583021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia, Hemolytic, Autoimmune--drug therapy<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Autoantibodies--immunology<br/>Erythropoietin--therapeutic use<br/>Female<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunologic Factors--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Retrospective Studies<br/>Rituximab<br/>Severity of Illness Index<br/>Splenectomy<br/>Steroids--therapeutic use<br/>Treatment Outcome<br/>Young Adult